February 14, 2022
Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division

Bio-Labs added a new product to the psychiatry division, Qualey (Quetiapine Fumarate). Bio-Labs is pleased and honored to help people take a step “Towards the Peak of Stability” through this product.

Around 50 million people struggle with mental disorders in Pakistan, and Qualey is their solution. It’s an FDA approved atypical antipsychotic that is ideal for treating Schizophrenia and Bipolar Disorder. In addition, it offers high efficacy with lesser side effects than other atypical antipsychotics.

article image